.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Citi
Chubb
Teva
Farmers Insurance
QuintilesIMS
Queensland Health
Boehringer Ingelheim
Argus Health
Colorcon

Generated: July 29, 2017

DrugPatentWatch Database Preview

AVAGE Drug Profile

« Back to Dashboard

What is the patent landscape for Avage, and when can generic versions of Avage launch?

Avage is a drug marketed by Allergan and is included in one NDA.

The generic ingredient in AVAGE is tazarotene. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the tazarotene profile page.

Summary for Tradename: AVAGE

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list2
Bulk Api Vendors: see list81
Patent Applications: see list4,350
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AVAGE at DailyMed

Pharmacology for Tradename: AVAGE

Ingredient-typeRetinoids
Drug ClassRetinoid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan
AVAGE
tazarotene
CREAM;TOPICAL021184-003Sep 30, 2002ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: AVAGE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan
AVAGE
tazarotene
CREAM;TOPICAL021184-003Sep 30, 2002► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cipla
Deloitte
Cantor Fitzgerald
Moodys
Queensland Health
Argus Health
Merck
US Department of Justice
Healthtrust
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot